These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3923516)

  • 1. Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys.
    Tang AH; Collins RJ
    Psychopharmacology (Berl); 1985; 85(3):309-14. PubMed ID: 3923516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.
    Locke KW; Gorney B; Cornfeldt M; Fielding S
    Psychopharmacology (Berl); 1989; 99(4):492-6. PubMed ID: 2556726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
    Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
    Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration.
    Gmerek DE; Dykstra LA; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):428-36. PubMed ID: 3302208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of morphine, ethylketocyclazocine, U-50,488H and naloxone on the acquisition of a classically conditioned response in the rabbit.
    Schindler CW; Gormezano I; Harvey JA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1010-7. PubMed ID: 3320342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
    Bhargava HN; Ramarao P; Gulati A
    Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
    Dykstra LA; Gmerek DE; Winger G; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):421-7. PubMed ID: 3302207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of kappa opioid agonists on the discriminative stimulus effects of cocaine in rhesus monkeys.
    Negus SS; Mello NK
    Exp Clin Psychopharmacol; 1999 Nov; 7(4):307-17. PubMed ID: 10609965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa opiate receptor agonists: effects on behavior and on brain function and structure in rhesus monkeys.
    Heath RG; Fitzjarrell AT; Walker CF
    Biol Psychiatry; 1984 Jul; 19(7):1045-74. PubMed ID: 6089918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF; Lahti RA; Ludens JH
    J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.
    Picker M; Dykstra LA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):938-45. PubMed ID: 3320348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of kappa opioids on cocaine self-administration by rhesus monkeys.
    Negus SS; Mello NK; Portoghese PS; Lin CE
    J Pharmacol Exp Ther; 1997 Jul; 282(1):44-55. PubMed ID: 9223538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities.
    France CP; Medzihradsky F; Woods JH
    J Pharmacol Exp Ther; 1994 Jan; 268(1):47-58. PubMed ID: 8301589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa receptor mediated opioid dependence in rhesus monkeys.
    Gmerek DE; Woods JH
    Life Sci; 1986 Sep; 39(11):987-92. PubMed ID: 3018406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U-50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists.
    Von Voigtlander PF; Lewis RA
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):467-70. PubMed ID: 6298890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats.
    Kapusta DR; Jones SY; DiBona GF
    J Pharmacol Exp Ther; 1989 Oct; 251(1):230-7. PubMed ID: 2552076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.